Richard Burr's Stock Trades: The COVID Sell and the STOCK Act's Biggest Test

In February 2020, Richard Burr was the chairman of the Senate Intelligence Committee. He had just attended a classified briefing on a novel coronavirus spreading from China that the public had not yet understood to be a serious threat.

Days later, he sold between $628,000 and $1.72 million in stocks — dumping positions across multiple sectors before the market's COVID collapse wiped out trillions in equity value.

The DOJ opened an investigation. The FBI seized his phone. No charges were ever filed.

The Burr COVID trade remains the closest the STOCK Act has ever come to a serious enforcement moment — and the most revealing example of why it hasn't produced one.

The Timeline

January 24, 2020: The Senate Intelligence Committee — chaired by Burr — received a classified briefing on COVID-19 from health officials. At this point, public messaging from the WHO and US officials was still reassuring. The market had not priced in a pandemic.

February 7, 2020: Burr attended another Senate briefing on the coronavirus threat.

February 13, 2020: Burr sold 33 stocks worth between $628,000 and $1.72 million. The sales spanned hotel stocks (Wyndham, Extended Stay), restaurants, and other consumer-facing companies — precisely the sectors that would be most devastated by pandemic lockdowns.

February 27, 2020: The S&P 500 began its COVID collapse, eventually falling 34% from peak to trough.

March 19, 2020: ProPublica reported on Burr's sales. Public outcry was immediate. Calls for his resignation followed.

May 2020: The DOJ opened a criminal investigation. The FBI executed a search warrant for Burr's phone.

September 2020: The DOJ closed the investigation without charges.

Burr did not seek re-election in 2022.

Why No Charges?

The DOJ's decision not to charge Burr after a full FBI investigation — including physical seizure of his communications device — was deeply significant.

Several factors likely contributed:

Evidentiary standard: Prosecutors would need to prove that Burr's trades were based on the specific MNPI from the classified briefing — not on public information, general pandemic concerns he could have developed from public news, or independent investment analysis. That's an extremely high bar. Burr's attorneys argued he relied on published research and public news reports.

Classification barriers: The content of the classified briefing itself could not be fully disclosed in court. Building a case around evidence the government can't fully present is structurally difficult.

Alternative explanations: Burr could argue that public news from China in January 2020 was already alarming to sophisticated observers — that he didn't need classified information to worry about a pandemic. This explanation may be implausible to many but plausible enough to prevent a conviction.

Political calculus: Whatever role political considerations play (and they inevitably do in high-profile political prosecutions), the DOJ under any administration faces scrutiny when prosecuting members of the opposing party.

The investigation's closure without charges was widely interpreted not as vindication of Burr's conduct but as a demonstration of how difficult STOCK Act prosecution actually is.

The Other COVID Traders

Burr wasn't alone. Several other senators made significant trades in the same window:

Kelly Loeffler (R-GA): Sold between $1.3M and $3.1M in stocks in the weeks after a January 24 classified Senate health briefing on COVID. She and her husband — who chairs the New York Stock Exchange — sold positions and purchased stock in a teleconferencing company (Citrix). DOJ investigated; no charges filed. She lost her Senate runoff election.

David Perdue (R-GA): Executed dozens of trades in the weeks following the briefings, including purchases in companies that would benefit from pandemic response. DOJ investigated; no charges filed. He also lost his Senate runoff.

Dianne Feinstein (D-CA): Her husband sold $1.5M–$6M in biotech stock (Allogene Therapeutics) in January 2020. Feinstein stated she had no involvement in her husband's investment decisions. No DOJ investigation resulted.

Jim Inhofe (R-OK): Sold $400K in stocks days after the briefing. No investigation resulted.

The pattern across multiple members — selling after a classified briefing on an impending crisis, before the market reflected that crisis — was the closest the STOCK Act has come to being tested against a systemic pattern rather than an individual case.

It produced zero convictions.

What the Burr Case Means for Congressional Trading Reform

The Burr case became the central argument in the push for stronger reform:

It demonstrated the information gap is real: Multiple senators received classified information about a coming market-disrupting event and appear to have traded on it. Their constituents, who funded those briefings through taxes, had no such advantage.

It demonstrated enforcement doesn't work: A full FBI investigation with phone seizure couldn't produce charges. The STOCK Act's prohibition on legislative MNPI trading is real; enforcing it apparently is not.

It drove the TRUST in Congress Act: The bipartisan response was renewed pressure for mandatory blind trusts. The bill passed the House and stalled in the Senate — where the members most affected by it are also the ones who must vote on it.

Tracking the Pattern on Cloakroom

The Burr case illustrates exactly what Cloakroom's AI Intent Score is designed to flag:

• Intelligence Committee chairman
• Sold consumer-facing sectors that would be devastated by a pandemic
• Sales clustered in the days following a classified briefing
• Disclosed within the 45-day window but well after the trades were executed

On Cloakroom's model, that combination — senior Intelligence Committee member, large-scale sells across consumer sectors, tight timing relative to a committee briefing — would score in the high 80s to low 90s.

You can't retroactively trade alongside Burr in February 2020. But you can set up the real-time alert system that would have surfaced those disclosures the day they were filed — not when ProPublica reported on them weeks later.

Track congressional disclosures in real time at Cloakroom.

---

All data sourced from public records and reporting. Cloakroom does not make investment recommendations or allege illegal conduct.